CancerIQ
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $19M
Investors
- 8
About CancerIQ
Based in Illinois, US, and founded in 2013, CancerIQ, Inc. operates as a software company. The company was founded by its CEO, Feyi Olopade Ayodele, CSO Olufunmilayo Olopade. In August 2024, CancerIQ, Inc. CancerIQ offers a cancer-focused precision health platform, which is a software platform that helps healthcare providers improve cancer prevention, early detection, and treatment for their patients. The software assists physicians in identifying patients who are at high risk for cancer, guiding them through the necessary tests and screening, and creating individualized care plans by utilizing genetic data and advanced analytics. The company’s solutions include risk assessment, patient navigation, care plan management, analytics, and revenue tracking.
Who invested in CancerIQ
8 investors across 3 rounds
See all investors in CancerIQ
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CancerIQ
Who invested in CancerIQ?
CancerIQ has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CancerIQ raised?
CancerIQ has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CancerIQ last raise money?
CancerIQ's most recent round on record is a Series B, in Mar 2022.
What does CancerIQ do?
Based in Illinois, US, and founded in 2013, CancerIQ, Inc.
Where is CancerIQ headquartered?
CancerIQ is headquartered in Chicago, US.
Which VCs invest in companies like CancerIQ?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at CancerIQ's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like CancerIQ? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.